Photo of Paolo Cortesi from researchgate.net
May 28, 2024, 14:17
Paolo Cortesi discusses the value of axi-cel as a second-line treatment in patients with R/R LBCL – VJHemOnc
VJHemOnc shared on X:
“Paolo Cortesi (The University of Milano–Bicocca) discusses the value of axi-cel as a second-line treatment in patients with R/R LBCL in an insightful interview from EBMT2024.
Click here to check it out.” .
Link to video.
Source: VJHemOnc/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023